Anticraving agents

What are adjunctive anticraving medications?

Anticraving medications includes naltrexone (an opioid receptor antagonist), which aims to reduce craving for and use of substances.

What is the evidence for anticraving medications?

Low quality evidence is unclear as to the benefit of anticraving agents such as naltrexone for improving substance dependence in people with schizophrenia.

September 2019

Last updated at: 4:51 am, 11th September 2019
To view documentation related to this topic download the files below
Fact Sheet Technical Commentary

NeuRA Libraries

Title Colour Legend:
Green - Topic summary is available.
Orange - Topic summary is being compiled.
Red - Topic summary has no current systematic review available.